Procedures for the measurement of acute mountain sickness
- PMID: 6661120
Procedures for the measurement of acute mountain sickness
Abstract
Although acute mountain sickness (AMS) has been studied for well over a century, a standard measure or index of the degree of illness for use in experimental research does not exist. This paper outlines a definition and procedures for an operational measurement of AMS using the Environmental Symptoms Questionnaire (ESQ). After 58 men completed over 650 ESQs during a stay of 1-3 weeks atop Pike's Peak (4300 m), factor analysis produced nine distinct symptom groups, with two factors representing AMS. The first factor contains symptoms indicative of cerebral hypoxia and is labeled AMS-C. The second reflects respiratory distress and is called AMS-R. Signal detection theory was used to establish a criterion score value for each factor. Standard deviation values were used to derive indices of sickness severity. Discussion is given to the possible relationships between the two types of AMS and the more serious conditions of cerebral and pulmonary edema.
Similar articles
-
The Environmental Symptoms Questionnaire in acute mountain sickness.Aviat Space Environ Med. 1985 Jun;56(6):572-5. Aviat Space Environ Med. 1985. PMID: 4015570
-
Validation of a shortened electronic version of the environmental symptoms questionnaire.High Alt Med Biol. 2007 Fall;8(3):192-9. doi: 10.1089/ham.2007.1016. High Alt Med Biol. 2007. PMID: 17824819
-
Comparing questionnaires for the assessment of acute mountain sickness.High Alt Med Biol. 2007 Fall;8(3):184-91. doi: 10.1089/ham.2007.8305. High Alt Med Biol. 2007. PMID: 17824818
-
[Mountaineering and altitude sickness].Ther Umsch. 2001 Jun;58(6):387-93. doi: 10.1024/0040-5930.58.6.387. Ther Umsch. 2001. PMID: 11441701 Review. German.
-
[Clinical aspects and pathophysiology of altitude sickness].Ther Umsch. 1993 Apr;50(4):216-20. Ther Umsch. 1993. PMID: 8378871 Review. German.
Cited by
-
Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial.BMC Pulm Med. 2019 Jul 24;19(1):134. doi: 10.1186/s12890-019-0890-y. BMC Pulm Med. 2019. PMID: 31340793 Free PMC article. Clinical Trial.
-
Effects of high-altitude exposure on supraspinal fatigue and corticospinal excitability and inhibition.Eur J Appl Physiol. 2017 Aug;117(8):1747-1761. doi: 10.1007/s00421-017-3669-y. Epub 2017 Jun 24. Eur J Appl Physiol. 2017. PMID: 28647868
-
Acetazolamide and dexamethasone in the prevention of acute mountain sickness.West J Med. 1988 May;148(5):541-5. West J Med. 1988. PMID: 3051673 Free PMC article. Clinical Trial.
-
Are nocturnal breathing, sleep, and cognitive performance impaired at moderate altitude (1,630-2,590 m)?Sleep. 2013 Dec 1;36(12):1969-76. doi: 10.5665/sleep.3242. Sleep. 2013. PMID: 24293773 Free PMC article. Clinical Trial.
-
Acute mountain sickness relates to sea-level partial pressure of oxygen.Eur J Appl Physiol Occup Physiol. 1995;70(6):469-76. doi: 10.1007/BF00634374. Eur J Appl Physiol Occup Physiol. 1995. PMID: 7556117
MeSH terms
LinkOut - more resources
Medical